Eye-Preserving Therapy in Retinoblastoma: Prolonged Primary Chemotherapy Alone or Combined with Local Therapy
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the efficacy of primary chemotherapy combined with local therapy in the treatment of retinoblastomas not treatable with a single therapeutic method. Methods: We performed a retrospective chart review of 227 patients diagnosed with retinoblastoma. Sixty-five eyes in 52 patients had tumors not treatable with a single therapeutic method and received primary chemotherapy combined with local therapy as needed. Results: Tumor control and eye salvage was achieved in 34 of the 65 eyes; the probability of ocular survival was 46.56% using the Kaplan-Meier method. Forty-three of the 65 eyes were group D or E tumors, in which tumor control and eye salvage was achieved in 16 eyes. Twenty eyes were treated with chemotherapy only, while 28 eyes received one additional modality of local therapy, and 17 eyes received two modalities of local therapy. Of the eyes treated with chemotherapy only, tumor control was achieved in 5 eyes. Conclusions: Primary chemotherapy combined with local therapy can be effective and safe in the treatment of retinoblastomas otherwise untreatable with other therapeutic methods, such as group D and E retinoblastomas. More vigorous treatment with more local therapeutic methods combined may yield even better results.
Abstract
Purpose: To evaluate the efficacy of primary chemotherapy combined with local therapy in the treatment of retinoblastomas not treatable with a single therapeutic method. Methods: We performed a retrospective chart review of 227 patients diagnosed with retinoblastoma. Sixty-five eyes in 52 patients had tumors not treatable with a single therapeutic method and received primary chemotherapy combined with local therapy as needed. Results: Tumor control and eye salvage was achieved in 34 of the 65 eyes; the probability of ocular survival was 46.56% using the Kaplan-Meier method. Forty-three of the 65 eyes were group D or E tumors, in which tumor control and eye salvage was achieved in 16 eyes. Twenty eyes were treated with chemotherapy only, while 28 eyes received one additional modality of local therapy, and 17 eyes received two modalities of local therapy. Of the eyes treated with chemotherapy only, tumor control was achieved in 5 eyes. Conclusions: Primary chemotherapy combined with local therapy can be effective and safe in the treatment of retinoblastomas otherwise untreatable with other therapeutic methods, such as group D and E retinoblastomas. More vigorous treatment with more local therapeutic methods combined may yield even better results.
참고문헌 (23)
- Singh AD, "Prognostic factors in retinoblastoma", J Pediatr Ophthalmol Strabismus, 37, pp.134~141 (2000)
- Gunduz K, "Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation", Ophthalmology, 111, pp.1917~1924 (2004)
- Eng C, "Mortality from second tumors among long-term survivors of retinoblastoma", J Natl Cancer Inst, 85, pp.1121~1128 (1993)
- Imhof SM, "Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma", Ophthalmology, 103, pp.263~268 (1996)
- Kaste SC, "Orbital development in long-term survivors of retinoblastoma", J Clin Oncol, 15, pp.1183~1189 (1997)
- Kim JH, "Clinical result of prolonged primary chemotherapy in retinoblastoma patients", Korean J Ophthalmol, 17, pp.35~43 (2003)
- Reese AB, "The evaluation and current concept of retinoblastoma therapy", Trans Am Acad Ophthalmol Otolaryngol, 67, pp.164~172 (1963)
- Beck MN, "First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma", J Clin Oncol, 18, pp.2881~2887 (2000)
- Shields CL, "Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors", Am J Ophthalmol, 138, pp.329~337 (2004)
- Shields CL, "Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation", Am J Ophthalmol, 133, pp.657~664 (2002)
- Brichard B, "Combined chemotherapy and local treatment in the management of intraocular retinoblastoma", Med Pediatr Oncol, 38, pp.411~415 (2002)
- Shields CL, "Chemoreduction in the initial management of intraocular retinoblastoma", Arch Ophthalmol, 114, pp.1330~1338 (1996)
- Murphree AL, "Chemotherapy plus local treatment in the management of intraocular retinoblastoma", Arch Ophthalmol, 114, pp.1348~1356 (1996)
- Gallie BL, "Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy", Arch Ophthalmol, 114, pp.1321~1328 (1996)
- Shields CL, "Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma", Ophthalmology, 104, pp.2101~2111 (1997)
- Shields CL, "Practical approach to management of retinoblastoma", Arch Ophthalmol, 122, pp.729~735 (2004)
- Linn Murphree A, "Intraocular retinoblastoma: the case for a new group classification", Ophthalmol Clin North Am, 18, pp.41~53 (2005)
- Campinchi R, "Does chemotherapy have a role in the treatment of retinoblastomas?", Bull Soc Ophtalmol Fr, 76, pp.17~22 (1976)
- Wilson MW, "Chemotherapy for eye cancer", Surv Ophthalmol, 45, pp.416~444 (2001)
- Pratt CB, "Topical topic: use of chemotherapy for retinoblastoma", Med Pediatr Oncol, 31, pp.531~533 (1998)
- Shields CL, "Recent developments in the management of retinoblastoma", J Pediatr Ophthalmol Strabismus, 36, pp.8~18 (1999)
- Cohen VM, "The success of primary chemotherapy for group D heritable retinoblastoma", Br J Ophthalmol, 93, pp.887~890 (2009)
- Shields CL, "Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes", Ophthalmology, 116, pp.544~551 (2009)